Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical: Archive
The Zacks Analyst Blog Highlights UnitedHealth, Pfizer, BlackRock, The Hershey and Edison International
by Zacks Equity Research
UnitedHealth, Pfizer, BlackRock, The Hershey and Edison International are part of the Zacks top Analyst Blog.
UNHPositive Net Change PFEPositive Net Change EIXNegative Net Change BLKNegative Net Change HSYPositive Net Change
consumer-staples finance medical pharmaceuticals utilities
Zacks Investment Ideas feature highlights: Exact Sciences, Kaiser Aluminum and Atmus Filtration Technologies
by Zacks Equity Research
Exact Sciences, Kaiser Aluminum and Atmus Filtration Technologies are part of the Zacks Investment Ideas article.
KALUNegative Net Change EXASNegative Net Change ATMUNegative Net Change
industrial-products medical
3 Buy-Rated Stocks Flexing Relative Strength
by Derek Lewis
While the market has taken a small breather as of late, there have been many big-time winners throughout the last month, including these three. Analysts are bullish on their outlooks, with all three carrying a favorable Zacks Rank.
KALUNegative Net Change EXASNegative Net Change ATMUNegative Net Change
biotechnology industrial-products medical
Top Analyst Reports for UnitedHealth, Pfizer & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including UnitedHealth Group Incorporated (UNH), Pfizer Inc. (PFE) and BlackRock, Inc. (BLK).
UNHPositive Net Change PFEPositive Net Change EIXNegative Net Change BLKNegative Net Change HSYPositive Net Change OSKNegative Net Change
finance medical pharmaceuticals
Market Jitters: 2 Top Ranked Stocks for Defensive Positioning
by Ethan Feller
With the jump in inflation and rise in interest rate uncertainty investors may want to consider defensive stocks
DVANegative Net Change HCANegative Net Change
hospitals medical
Here's Why You Should Add DaVita (DVA) to Your Portfolio
by Zacks Equity Research
DaVita's (DVA) strength in its kidney care raises optimism about the stock.
ECLPositive Net Change DVANegative Net Change CAHPositive Net Change LMATNegative Net Change
medical medical-devices
Integer Holdings (ITGR) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Integer Holdings' (ITGR) research and product development activities.
ECLPositive Net Change DVANegative Net Change CAHPositive Net Change ITGRNegative Net Change
medical medical-devices
Will UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q1 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) first-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues and the number of people it served.
UNHPositive Net Change UHSNegative Net Change EWNegative Net Change INSPNegative Net Change
earnings medical
Reasons to Hold Baxter International (BAX) in Your Portfolio
by Zacks Equity Research
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.
BAXNegative Net Change DVANegative Net Change CAHPositive Net Change LMATNegative Net Change
medical medical-devices
Align Technology (ALGN) Up 20.5% YTD: Will the Rally Continue?
by Zacks Equity Research
Investors are optimistic about Align Technology (ALGN) driven by geographic expansion and upbeat guidance.
SYKNegative Net Change ALGNNegative Net Change CAHPositive Net Change CORPositive Net Change
medical medical-devices
Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
by Zacks Equity Research
Data from an early-stage study shows that treatment with Moderna's (MRNA) experimental cancer therapy achieved positive clinical response in patients with a specific type of head and neck cancer.
MRKNegative Net Change MRNAPositive Net Change ANIPNegative Net Change ADMAPositive Net Change
biotechs medical messenger-rna pharmaceuticals vaccines
Best Momentum Stocks to Buy for April 10th
by Zacks Equity Research
DELL, AGRO and SIGA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 10, 2023.
DELLPositive Net Change AGRONegative Net Change SIGANegative Net Change
computers medical
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
DVANegative Net Change CAHPositive Net Change FMSNegative Net Change CORPositive Net Change
medical medical-devices
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
by Zacks Equity Research
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
DVANegative Net Change CAHPositive Net Change MMSINegative Net Change CORPositive Net Change
medical medical-devices
Boston Scientific (BSX) Faces Rising Costs, Competition
by Zacks Equity Research
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
BSXPositive Net Change SYKNegative Net Change CAHPositive Net Change CORPositive Net Change
medical
Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study
by Zacks Equity Research
Nurix (NRIX) rises on initial findings of clinical responses in the brain for its investigational targeted protein degrader, NX-5948, which is currently under development to treat B cell malignancies.
SNYNegative Net Change AZNNegative Net Change RHHBYNegative Net Change NRIXNegative Net Change
biotechnology biotechs medical oncology-screening pharmaceuticals
Neogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands
by Zacks Equity Research
Neogen's (NEOG) third-quarter fiscal 2024 results reflect solid core revenue growth in both segments.
CAHPositive Net Change NEOGPositive Net Change PODDNegative Net Change EXASNegative Net Change
earnings medical medical-devices
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
by Nalak Das
We have narrowed our search to five high-flying Nasdaq Composite listed non-tech stocks with more upside left. These are: CELH, SWAV, COIN, HOOD, IBKR.
IBKRNegative Net Change CELHNegative Net Change SWAVPositive Net Change COINNegative Net Change HOODNegative Net Change
consumer-staples finance medical
New Strong Buy Stocks for April 10th
by Zacks Equity Research
DELL, WEAV, AGRO, SIGA and STEP have been added to the Zacks Rank #1 (Strong Buy) List on April 10, 2023.
DELLPositive Net Change AGRONegative Net Change SIGANegative Net Change STEPNegative Net Change WEAVNegative Net Change
computers consumer-staples finance medical
Bear of the Day: IPG Photonics (IPGP)
by Bryan Hayes
Earnings for this developer of high-performance lasers are expected to plummet this year.
IPGPPositive Net Change
communications construction earnings investing medical tech-stocks
Why HCA Healthcare (HCA) is a Smart Addition to Your Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) remains well-poised for growth on growing patient volumes, buyouts, effective telehealth services and a notable financial stand.
HCANegative Net Change LNTHPositive Net Change MEDPPositive Net Change OGNNegative Net Change
medical
Elevance Health (ELV) Brand Inks Deal to Better Serve Georgia
by Zacks Equity Research
Elevance Health's (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmont's healthcare network available to its members across specific Georgia regions.
DVANegative Net Change EWNegative Net Change IDXXPositive Net Change ELVPositive Net Change
medical
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
by Zacks Equity Research
Though early-stage results on Vincerx's (VINC) experimental drug did show signs of anti-tumor activity, the share price drops as some analysts stated that the results were below expectations.
LGNDNegative Net Change ANIPNegative Net Change ADMAPositive Net Change VINCNegative Net Change
biotechs medical
Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data
by Zacks Equity Research
Bristol Myers' (BMY) Krazati, in combination with cetuximab, demonstrates clinically meaningful activity as a targeted treatment option for patients with previously treated KRASG12C-mutated locally advanced or metastatic colorectal cancer.
BMYNo Net Change ANIPNegative Net Change ADMAPositive Net Change GLPGNegative Net Change
biotechnology medical pharmaceuticals
Brookdale Senior (BKD) Sees Y/Y Increase in Q1 Occupancy Levels
by Zacks Equity Research
Brookdale Senior (BKD) witnesses 29 straight months of year-over-year increases in weighted average occupancy level.
UHSNegative Net Change CIPositive Net Change BKDNegative Net Change HCATNegative Net Change
medical